Literature DB >> 7519584

Fibroblast activation protein: purification, epitope mapping and induction by growth factors.

W J Rettig1, S L Su, S R Fortunato, M J Scanlan, B K Raj, P Garin-Chesa, J H Healey, L J Old.   

Abstract

The human fibroblast activation protein (FAP) defined by monoclonal antibody (MAb) F19 is a cell surface antigen expressed in reactive stromal fibroblasts of breast, colorectal, lung and other epithelial cancers. In contrast to its stroma-specific localization in epithelial neoplasms, FAP is expressed in the malignant mesenchymal cells of bone and soft tissue sarcomas. FAP is transiently expressed in some fetal mesenchymal tissues but is absent or expressed at low levels in most adult tissues. FAP is induced in cultured fibroblasts and, in these cells, consists of a M(r) 95,000 subunit (FAP alpha) carrying the F19 epitope and a non-covalently bound M(r) 105,000 subunit (FAP beta) lacking the F19 epitope. Using MAb F19 and 5 newly derived MAbs, we identify 3 distinct epitopes on FAP alpha and tentatively assign one epitope to FAP beta. Analysis of detergent extracts of a FAP alpha high beta- sarcoma cell line by size exclusion-high performance liquid chromatography (HPLC) revealed that FAP alpha does not elute as a M(r) 95,000 species but as part of a high-molecular weight complex (M(r) > 400,000) that dissociates into M(r) 95,000 subunits in SDS gels. Immunoaffinity purification of FAP alpha followed by tryptic digestion, reversed-phase HPLC and microsequencing identified 3 unique FAP alpha peptides, with 2 showing sequence similarity (23/38 identical amino acids) to segments of CD26, a T-cell activation antigen. CD26 is a membrane-bound enzyme (dipeptidyl aminopeptidase IV), but immunopurified FAP alpha has little if any dipeptidase activity with typical CD26 substrates. Finally, studies with FAPlow leptomeningeal fibroblasts revealed that transforming growth factor-beta, 12-O-tetradecanoyl phorbol-13-acetate and retinoids can upregulate FAP expression, whereas serum and several other factors had no or little effect on FAP levels. FAP and CD26 may belong to a family of structurally related but functionally distinct activation proteins that are expressed on different cell types and show unique modes of regulation in normal and malignant cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519584     DOI: 10.1002/ijc.2910580314

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  30 in total

1.  Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas.

Authors:  Y T Chen; E Stockert; A Jungbluth; S Tsang; K A Coplan; M J Scanlan; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV.

Authors:  Victoria J Christiansen; Kenneth W Jackson; Kyung N Lee; Patrick A McKee
Journal:  Arch Biochem Biophys       Date:  2006-11-17       Impact factor: 4.013

Review 3.  The role of fibroblast activation protein in health and malignancy.

Authors:  Allison A Fitzgerald; Louis M Weiner
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

4.  Targeted disruption of mouse fibroblast activation protein.

Authors:  J Niedermeyer; M Kriz; F Hilberg; P Garin-Chesa; U Bamberger; M C Lenter; J Park; B Viertel; H Püschner; M Mauz; W J Rettig; A Schnapp
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

5.  Activation of EDTA-resistant gelatinases in malignant human tumors.

Authors:  Donghai Chen; Alanna Kennedy; Jaw-Yuan Wang; Wei Zeng; Qiang Zhao; Michael Pearl; Mengzhen Zhang; Zhenhe Suo; Jahn M Nesland; Yuhuan Qiao; Ah-Kau Ng; Naoko Hirashima; Tetsu Yamane; Yoshiyuki Mori; Masako Mitsumata; Giulio Ghersi; Wen-Tien Chen
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

6.  Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion.

Authors:  Maria L Henriksson; Sofia Edin; Anna M Dahlin; Per-Arne Oldenborg; Åke Öberg; Bethany Van Guelpen; Jörgen Rutegård; Roger Stenling; Richard Palmqvist
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

7.  Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer.

Authors:  Julia Tchou; Paul J Zhang; Yingtao Bi; Celine Satija; Rajrupa Marjumdar; Tom L Stephen; Albert Lo; Haiying Chen; Carolyn Mies; Carl H June; Jose Conejo-Garcia; Ellen Puré
Journal:  Hum Pathol       Date:  2013-09-26       Impact factor: 3.466

8.  Elevation of seprase expression and promotion of an invasive phenotype by collagenous matrices in ovarian tumor cells.

Authors:  Alanna Kennedy; Huan Dong; Donghai Chen; Wen-Tien Chen
Journal:  Int J Cancer       Date:  2009-01-01       Impact factor: 7.396

9.  Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase.

Authors:  Sarah E Poplawski; Jack H Lai; Youhua Li; Zhiping Jin; Yuxin Liu; Wengen Wu; Yong Wu; Yuhong Zhou; James L Sudmeier; David G Sanford; William W Bachovchin
Journal:  J Med Chem       Date:  2013-04-29       Impact factor: 7.446

10.  Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.

Authors:  Angélica M Santos; Jason Jung; Nazneen Aziz; Joseph L Kissil; Ellen Puré
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.